IL2 and cancer: Recent studies have shown that IL-2 is a key cytokine that affects the differentiation of immune cells and has pleiotropic effects: it not only activates effector T cells to promote immune response but also promotes Treg cell proliferation to maintain immune tolerance, playing important roles in infection, autoimmune diseases, and cancer.